Variant report
Variant | nsv555942 |
---|---|
Chromosome Location | chr11:93682348-93688514 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr11:93680099..93683642-chr11:93684474..93688848,4 | K562 | blood: | |
2 | chr11:93684701..93687298-chr11:93690286..93693320,3 | K562 | blood: | |
3 | chr11:93687985..93689849-chr11:93692203..93693783,2 | K562 | blood: | |
4 | chr11:93680099..93683642-chr11:93684474..93688848,4 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs2000960 | chr11:93682348-93682349 | Enhancers Bivalent Enhancer | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
2 | rs111435685 | chr11:93682356-93682357 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
3 | rs7944194 | chr11:93682413-93682414 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
4 | rs80026797 | chr11:93682431-93682432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs147596435 | chr11:93682466-93682467 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs142046324 | chr11:93682467-93682468 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs558670405 | chr11:93682515-93682516 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577512835 | chr11:93682546-93682547 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs544531360 | chr11:93682600-93682601 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
10 | rs563104080 | chr11:93682625-93682626 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
11 | rs116957276 | chr11:93682752-93682753 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
12 | rs574376453 | chr11:93682791-93682792 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
13 | rs202030370 | chr11:93682793-93682794 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
14 | rs191845327 | chr11:93682802-93682803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs543442096 | chr11:93682813-93682814 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs183576811 | chr11:93682837-93682838 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs546616767 | chr11:93682870-93682871 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs140513045 | chr11:93682884-93682885 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571156155 | chr11:93682886-93682887 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs386756293 | chr11:93682887-93682888 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs55649862 | chr11:93682888-93682889 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs569049948 | chr11:93682905-93682906 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs75404199 | chr11:93682909-93682910 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs2462744 | chr11:93682913-93682914 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs566663250 | chr11:93682921-93682922 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs569290195 | chr11:93682950-93682951 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs186750078 | chr11:93683063-93683064 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
28 | rs558914689 | chr11:93683111-93683112 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
29 | rs145807599 | chr11:93683157-93683158 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
30 | rs575429353 | chr11:93683158-93683159 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
31 | rs111741521 | chr11:93683163-93683164 | Enhancers Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
32 | rs373548788 | chr11:93683209-93683210 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs148192635 | chr11:93683232-93683233 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs142009138 | chr11:93683286-93683287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs542478886 | chr11:93683332-93683333 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs75216809 | chr11:93683346-93683347 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532540862 | chr11:93683350-93683351 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs181469661 | chr11:93684001-93684002 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
39 | rs543904582 | chr11:93684047-93684048 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
40 | rs184699961 | chr11:93684083-93684084 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
41 | rs188621732 | chr11:93684084-93684085 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
42 | rs548040420 | chr11:93684170-93684171 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
43 | rs549849050 | chr11:93684187-93684188 | Bivalent Enhancer | n/a | n/a | Overlapped CNVs | n/a |
44 | rs2511398 | chr11:93684809-93684810 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
45 | rs151214920 | chr11:93684812-93684813 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs564304130 | chr11:93684847-93684848 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs2460057 | chr11:93684902-93684903 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs550261047 | chr11:93684938-93684939 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568483610 | chr11:93684985-93684986 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs7942236 | chr11:93685031-93685032 | Bivalent Enhancer Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Gastric cancer | 17908304 | CNVD |
Multiple myeloma | 20724749 | CNVD |
Wilms tumour | 21544195 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Non-small cell lung cancer | 21385341 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Cancer | 21637783 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Chronic lymphocytic leukemia | 21795749 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Oral cancer | 21386901 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 20837533 | CNVD |
Breast cancer | 21264507 | CNVD |
Cervical cancer | 21063398 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Liposarcoma | 21253554 | CNVD |
Neuroblastoma | 18923524 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Cancer | 16751803 | CNVD |
Seminomas | 18059402 | CNVD |
Cervical cancer | 21062161 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Cancer | 22429812 | CNVD |
Breast cancer | 16608533 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Hepatocellular carcinoma | 16785998 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21858162 | CNVD |
Breast cancer | 21785460 | CNVD |
Cancer | 22183965 | CNVD |
Melanoma | 22183965 | CNVD |
Developmental delay | 21147756 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21958427 | CNVD |
Lung cancer | 18438408 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Malignant fibrous histiocytomas | 21085701 | CNVD |
Breast cancer | 17133270 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Ductal carcinoma | 22052326 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Mental retardation | 21062444 | CNVD |
Cancer | 21499728 | CNVD |
Breast cancer | 19181860 | CNVD |
Breast cancer | 17603634 | CNVD |
Mantle cell lymphoma | 19029149 | CNVD |
T-cell acute lymphoblastic leukemia | 18185524 | CNVD |
Basal cell lymphoma | 16790693 | CNVD |
Breast cancer | 21509527 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bipolar disorder | 19114987 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr11:93681400-93682400 | Enhancers | Foreskin Keratinocyte Primary Cells skin02 | Skin |
2 | chr11:93681400-93682400 | Enhancers | NHEK | skin |
3 | chr11:93681400-93683400 | Enhancers | HMEC | breast |
4 | chr11:93681600-93682400 | Enhancers | HSMM | muscle |
5 | chr11:93681600-93683000 | Enhancers | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
6 | chr11:93681600-93683200 | Enhancers | Mesenchymal Stem Cell Derived Adipocyte Cultured Cells | ES cell derived |
7 | chr11:93681800-93682400 | Enhancers | HSMMtube | muscle |
8 | chr11:93681800-93683000 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
9 | chr11:93682200-93682400 | Bivalent Enhancer | Bone Marrow Derived Cultured Mesenchymal Stem Cells | Bone marrow |
10 | chr11:93682200-93682600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
11 | chr11:93682600-93682800 | Bivalent Enhancer | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
12 | chr11:93683000-93683200 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
13 | chr11:93684000-93684200 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
14 | chr11:93684800-93686400 | Enhancers | HepG2 | liver |
15 | chr11:93685000-93685800 | Bivalent Enhancer | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
16 | chr11:93687000-93687800 | Enhancers | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |